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OBJECTIVE: To quantify the familial contribution to mUI-
lerian anomalies and determine a possible inheritance 
pattern. 
METHODS: Cases of mOllerian anomalies, identified by 
International Classification of Diseases and Current Pro-
cedural Terminology codes from January 1994 to March 
2006/ were collected from the largest hospital systems in 
the state of Utah. All records were subsequently matched 
to the Utah Populalion Database. Controls for this data 
set were randomly selected and matched based on birth 
year and gender. Highly specialized software "Kinship 
Analysis Tools (KAT)" was used for kinship analysis. 
RESULTS: A total of 1,397 cases qualified for the final 
analysis. The kinship analysis tool identified 27 family 
dusters. The mean familia! standardized incidence ratio 
was 3.43( P<.01). Using the adjusted "Population Attrib-
utable Risk," approximately 10% of cases of mOllerian 
anomalies appear to be attributable to a familial associ-
ation. The relative risk for mOllerian anomalies in -each 
class of kinship was as follows: first-degree relatives 11.6 
(95% confidence interval [Cll 5.42-24.82), parents/chil-
dren 8.78 (95% CI 2.26-34.16), siblings 12.98 (95% CI 
5.17-32.62), first cousins 1.44 (95% CI 0.76-2.76), and 
second cousins 1.30 (95% CI 0.96-1.77). 
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CONClUSION: MUllerian anomalies have a strong fa-
milial aggregation and follow a polygenic and multifac-
torial inheritance. 
(Obstet Cyncco/ 2008;111:378-84) 
LEVEL OF EVIDENCE: II 
M iillerian anomalies are perhaps the most com-mon of all developmental anomalies. They 
have been identified in approximately 2-3% of fertile 
'women. l Because they are frequently lUldiagnosed, a 
precise estimation of their contribution to poor repro-
ductive outcomes is not available. But uterine anom-
alies are associated with increased risks for spontane-
ous abortion, infertility, ectopic pre,gnancies, preterm 
labor, and fetal malpresentation.'·' 
The etiology of these developmental disorders is 
unknm.vn. It has been suggested that genetic factors 
may contribute to the formation of millierian anom-
alies. -Hi Exposure to environmental xenobiotics dur-
ing fetal life was also proposed as a potential contrib-
utor to the development of miillerian anomalies.1O-15 
In consequence, miillerian anomalies would likely be 
found in families that share similar genetic predispo-
sition and environmental exposures. Evidence for a 
familial predisposition for miillerian anomalies has 
been presented in multiple reports examining individ-
uals or small nrunhers of familiesYi-19 However, the 
inheritance pattern remains poorly defined, and work 
to date has been limited by the relatively low inci-
dence of the malformations, incomplete diagnosis, 
and the variability of phenotypic expression. The 
ability to identify multiple families that have multiple 
individuals diagnosed with miillerian anomalies is a 
critical step in understanding the familial character 
and the mode of inheritance of these anomalies. The 
University of Utah has a powerful tool, the Utah 
Population Database, that allows the identification of 
such families. This database provides access to data 
concerning approximately six million individuals. 
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The central component of the Utah Population Data-
base is an extensive set of Utah family histories, in 
which family members are lin ked to demogTaphic 
and medical infornlation. There are about six million 
individuals linked into multi-generational families 
with pedigrees spanning as many as 11 generatioI1s.:.!o 
The statistical tools available through the Utah Pop-
ulation Database have facilitated the familial analyses 
of a number of diseases and conditions, such as 
preeclampsia and canccrs,21-2'l In this study, the Utah 
Population Database was used to perform a kinship 
analysis of a large number of individuals affected "'\lith 
mi.illerian anomalies to describe the familiality of the 
disease and to determine possible inheritance 
patterns~ 
MATERIALS AND METHODS 
After respective institutional review board approvals 
from the University of Utah and Intermountain 
Health Care, data were collected for all patients with 
miillerian anomalies \vho were diagnosed in hospitals 
and related clinics of the two major health provider 
systems in the state of Utah (University of Utah and 
Intermountain Health Care system) over the period 
extending from January 1994 to March of 2006. The 
extent of the study \vas nlainly determined by the 
availability of computerized diagnosis and billing 
records in the hospitals because most of cases were 
identified through the International Classification of 
Diseases, 9th Rcyision (TCD-9) and Current Proce-
dural Terminology codes. The ICD-9 codes used for 
the screening for mtillerian anonlalies '","ere the fol-
lowing: 752.2 (doubling of uterus) and 752.3 (other 
anomalies of uterus). The Current Procedural Termi-
nology used were 58560 (hysteroscopy with division 
or resection of uterine septum, 57130 (excision of 
vaginal septum), and 5R540 (hysteroplasty with repair 
of uterine anomaly (Strassman type). The accuracy of 
these ICD-9 and Current Procedural Terminolob'Y 
codes in reflecting the correct diagnosis of mtillerian 
anomalies was tested by reviewing the medical record 
of a random sample of 346 patients. The accuracy of 
the diagnosis of mi.illerian anomaly reflected by the 
ICD-9 and Current Procedural Terminology codes 
was 91.9% (318 of 346). The distribution of anomalies 
in the 318 affected patients is given in Table 1. The 
remaining patients had the following diagnosis: eight 
uterine polyps, seven leiomyomata, four Asherman 
syndrome (intrauterine adheSion), three ovarian cysts, 
one vaginal hysterectomy, one cesarean for breech, 
one dilation and curettage for miscarriage, one tubal 
occlusion on hysterosalpingograrn, one normal h)'s-
ierosalpingogram, and one uterine cancer. 
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Table 1. Distribution of Miillerian Anomalies in 
the Sample Patients 
Diagnosis No. of Patients Frequency (%) 
Septate incomplete 87 27.4 
Bicornuate 76 23.9 
Sepiale complete 41 12.9 
Didelphis 29 9.1 
Arcuate '27 8.5 
Unicornuare 27 8 . .1 
MUllerian aplaSia IS 4.7 . 
Transverse septum S 1.6 
I,ongitudinal septum 4 1.3 
Possible seplum 4 1.3 
Septate vs bicornuate 3 0.9 
ToLa.! 318 100.0 
The majority of hospitals and related clinics 
(90010), including the major health systems in the state. 
provided the requested records allOWing the identifi-
cation of most cases of mtillerian anomalies diagnosed 
in the state of Utah over the last 12 years. The 
geographic distribution of these hospitals covered all 
the populated areas of the state of Utah (Fig. 1). After 
collection of cases, patients' identifiers were used to 
link patients to matching data present in the Utah 
Population Database. Controls were individuals who 
did not have uterine anomalies (not part of the case 
data set) and were randomly selected from the Utah 
Population Database by matching based on birth year 
and female gender. Five controls were selected for 
each case, and sampling "vas done \-'vithout replace-
Ulent so as not to use the controls lllultiple tinles. 
The kinship analysis was conducted by working 
with software developed and managed by the Utah 
Population Database. Highly speCialized software, 
Kinship Analysis Tools (KAT; University of Utah, 
Salt Lake City, UT), was used to estimate the magni-
tude of familial risk." These programs are highly 
efficient and specifically written to take advantage of 
the particular resources of Utall Population Database. 
There arc two sets of programs that the statistical team 
at the Utah Population Database uses. termed Dy-
naped a.nd Kinelass. The Dynaped allows calculation 
of familial disease incidence, familial average pheno-
types, identification of founders and estimation of 
individual family members' relative risks via pedi-
gree-stnlctured Poisson regression, and extension of 
the above methods to alternative inheritance lllodels. 
The Dynaped kinship analysis tool was used to find 
families ""'lith excess mi.illerian anomalies. Statistics 
computed for each frunily were the number of descen-
dants, observed nwnber of affected, expected number 
of affected, P value, familial standardi7.ed incidence 




I Utah I 
• Hospital 
• 
Fig. 1. A map for the state of Utah showing the geographical 
distribution of the hospitals that participated in the study. 
These hospitals serve most of the populated areas of the 
state. 
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ratio, and relative risk>. A familial standardized inci-
dence ratio is a kinship-, .. 'eighted average of the ratio 
of observed to expected incidence of disease among 
family members"'; The results were filtered to detect 
families that had at least live affeded descendants and 
a familial standardized incidence ratio statisticallv 
different from 1 (J'-';.Ol) to identify families with ~ 
clustering of anomalies. In these families J the ob-
served number of anomalies exceeded the expected 
number. Expected numbers were estimated by mul-
tiplying the overall population prevalence by the 
number of descendants in a family who could have 
been observed to have the disease. Also using the case 
control analysis, Dynaped allowed the calculation of 
the Population Attributable Risk, which is the propor-
tion of miillerian anomalies in our data set that can be 
attributed to fan1iliality. The second program, Kin-
class~ determines kinship relationships for a set of 
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individuals according to a desired set of criteIia, such 
as first-=. and second-degree relatives who are still alive. 
The Kindas; program was used to compute the 
loglstic regression for miillerian anomalies using the 
patients and the same set of controls and subsequently 
calculate the relative risk of having miillerian anom-
alies in each kinship class . 
RESULTS 
We identified 1,985 cases of suspected mtillerian 
anomalies based on the general ICD-9 and Current 
Procedural Terminology codes used for screening. 
Three hundred thirty cases in the data set could not 
be linked to Utah Population Database. Among the 
1,655 cases found in the Utah Population Database, 
eight cases \vere listed twice in the data set, \\"ith t\tVo 
different project identification numbers, and 250 
cases did not have parents or children recorded in the 
database, so they were dropped hom the analysis . 
The final number of cases available for the final the 
analysis that follows was 1,397 (Fig. 1). 
Using the kinship analysis function, we identified 
29 founders with families that had from five to 14 
Cases identified with high likelihood of 
Mullerian anomalies based on the specific 
International Classification Diseases and 
Current Procedural Terminology codes 
N=1.985 
Cases did not link to the Utah 
population database 
n=330 





Cases did not have any 
relatives 
n:=250 
Cases used in final kinship analysis 
n=1,397 
Fig. 2. A diagram of the study population. 
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Table 2. Family Clusters 
No. of No. of Affected 
Founder Descendants Family Members 
6,126 8 
2 3,146 7 
3 6.632 8 
4 3,767 7 
5 4,12X (5 
6 14,425 !J 
7 4,422 7 
8 2,016 5 
9 2,702 5 
10 2,294 6 
11 4,525 6 
12 2,951 5 
13 6.074 7 
14 9:676 7 
15 793 S 
16 1,079 5 
17 3,557 (; 
18 4.719 8 
19 5.482 8 
20 10.264 10 
21 1,:376 5 
22 4,071 6 
23 16,601 13 
24 4,445 (; 
25 5,463 7 
26 2,502 5 
27 7,001 H 
28 12,986 12 
29 4,217 6 
affected descendants and a pedigree size ranging from 
793 to 16,602 descendants (Table 2). Founders are 
individuals for whom there are no ancestral genealog-
ical relationships in the Utah Population Database. 
Thus, they are the earliest generation in the database. 
VOL. 111, NO.2, PART 1, FEBRUARY 2008 
-----------------------
Familial Standardized 95% Confidence 
Incidence Ratio Interval Clusters 
3_2 1.4-6.3 
3.3 l.3 ·6.H 
:1.4 1.5-6.7 2. 
4·,6 1.8-9 . .3 2b 
3.6 1.3-7.8 2c 
2.26 1.0-4.2 2d 
3.9 1.6-8.0 :1 
6.1 2.0-14.2 4 
4.5 1.5-10.5 5a 
6.4 2.:1-13.9 5b 
3.4 l.2-7.4 6 
4.2 1.4-9.8 7 
3.2 1.3-6.6 8 
2.9 1.2-6.0 9 
16.3 5.3-38.0 10 
11.7 3.8-27.3 HI 
4.2 1.5-9.1 11 
4.1 1.8-8.1 12 
4.0 1.7-7.9 13. 
2.5 1.2-4.6 13b 
8.7 2.8-20.3 14 
3.5 1.3-7.6 15 
2.1 1.1-3.6 16 
4.1 1.5-8.9 17a 
3.7 1.5-7.6 17b 
5.2 1.7-12.1 18 
2.8 1.2-5.5 19 
2.3 1.2-4.0 20 
3.7 1.4-8.1 21 
Further analysis identified the 256 affected descen-
dants of these 29 founders. Careful analysis of these 
affected individuals showed that they constituted 27 
family clusters, with some clusters haVing more than 
one founder. Also, SOllle of the clusters shared some, 
Fig. 3. A pedigree showing a family 
with an increased risk of mullerian 
anomalies by the study criteria (at 
least five affected family members 
and a familial standardized inci-
dence ratio significantly different 
from 1). Circle, female; square, 
male: crossed. deceased; black, 
anomaly. 
Hammoud Famili.3lity of Mullerian 
AnomJ/ies. Obstet Gynecol 2008. 
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but not all, affected descendants (Table 2). An exam-
ple of these family clusters is b~ven in Figure 3. 
j,lemhers of these families bad a threefold bigher risk 
of mullerian anomalies than conh'ols (the mean famil-
ial standardized incidence ratio was 3,,1,3, with P<.Ol, 
compared with all families combined). Apart from the 
previous fanlily sets, we searched for families that had 
h'{o or lllOre aflected first- or second-degree lanlily 
members (mothers-daughters, sisters, and aunts-
nieces). We successfully identified multiple families, 
illcludhlg three sets of aunt-nieces, four sets of moth-
er-daughters, lO sets of two sisters, and tvvo sets of 
three sisters .. An example of such families is brivCll in 
Figure ,1·. 
The case control analysis was used La calculate 
the Population Attributable Risks. Using the adjusted 
Population Attributable Risks, the dsk for miilledan 
anomalies attdbutable to familial affiliation approxi-
mates 10% (9.1% confidence interval 7-13010). 
The relative risks for each kinship class \'\tere com-
puted using conditional logistic regression. The Kinclass 
progTam uses the same control set that Dynaped used 
above, with five controls per case matched based on 
birth year and gender. 11,e relative risk per kinship class 
is given in Table 3. 11,ere appears to be a nearly 12-fold 
increase in risk for miillerian anomaly for first-degree 
relatives of alIected individuals. The relative dsk for first 
cousins is approximalely 1. t, and for second cousins it is 
1.3. The relatively large drop in risk from siblings to 
cousins sugb""ts .a polygenetic/multifactodal mode of 
inheritance. 
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Fig. 4. A pedigree that has three 
affected sislers. One of the sisters 
presented 'vvilh primary amenorrhea 
,md the absence of a cervix on 
physical examination. Circle. fe-
male; square, male; diamond, sex 
undelermined; crossed, deceased; 
black. anomaly. 
Hammoud. Familialitv of l\.'lullcrian 
Anomalies. Obstct CYncco/2008. 




























In this smdy, we found strong evidence for familialily 
contdbuting to mullerian anomalies. Differentiating 
between genetic and environmental contributions is 
particularly difficult when studying families because 
family menlbers most often share not ouly genetic 
predisposition but also environmental exposures. The 
relative risk of having a mtillerian anomaly in a 
first-del,'Tee relative of an affected individual is more 
lhan 12 times higher than controls. Increased risk 
remains detectable in distant relatives as far as sec-
ond-de,bJTec cousins, denoting a strong genetic cle-
ment However) in addition to genetic predisposition, 
socioeconomic and geographic factors (such as envi-
ronmental exposures and access to health care) may 
also contribute lo the development of and/or detec-
tion of mulledan anomalies. This is suggested by the 
magnitude of the elevated risk in immediale family 
members (parents and Siblings) in comparison \'\lith 
the modest increase in second cousins. Indeed, the 
pattern of familial clustering of cases of uterine mal-
formations is consistent with polygenetic/multifacto-
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rial disorders. In these conditions, genetic predisposi-
tion and local or cnvironmental factors contribute to 
the likelihood of diagnosis of miillerian anomalies for 
close family members l whereas more distant relatives 
are only affected by genetic predisposition. 
A potential source of bias in this study may be due 
to ihe possibility of case clustering among close relaLives 
oVling to heightened a\vareness of these conditions and 
common access to diagnosis. Alternatively, mtillerian 
anomalies can be associated \",'ith normal reproductive 
funcLion and can remain undiagnosed in affected indi-
viduals. The undiagnosed cases will conttibute to an 
lmderestimation of the prevalence of miillerian anoma-
lies and to an underestimation of their familial character. 
We believe that targeted screening of families of cases 
and families of controls m,ing three-dimensional ultra-
sonowaphy or magnetic resonance imaging will yield a 
stronger evi dence of fam1lialityc 
This analysis included different types of mullerian 
anomalies that may be caused by different genetic 
alterations. This may account for the varying pheno-
typic expressions observed in this study. A kinship 
analysis of speCific types of anomalies might yield a 
monogenetic phenotype. Hmvever, the observation that 
members of the same family had different phenotypic 
expression of mullerian anomalies (Fig. 4) does not 
support a specific genetic etiology for each type of 
anomaly. 
In terms of the ability to generalize these finding, 
ibis study represents U.S. families \-vith ancestry from 
Nor.thern and VVestcm Europe. Extensive investiga-
tion of the families in the Utah Population Database 
reveals that it is a noninbred population and is 
representative of the white population of the United 
States.2fi.27 Thc representative nature of the population 
can be explained by several factors, such as the large 
founding size, the high rates of gene flow, and ances-
tors with diverse countries of origin. Using this rc-
source, discoveries such as the BRCA I and BRCd42 
breast cancer mutation28,2fl and the APC gene muta-
tion in colon cancer were made.:)I) 
Our study provides insight into the familial distri-
bution of miillerian anomalies based on the analysis of a 
large number qf affected individuals by using population 
analysis tcclmiques unique to the Utah Population Da-
tabase. This analYSis should be extended by familial 
kinship studies based on different types of anomalies 
and by studies employing sensitive diaS'llostic tech-
niques for uterine morpholOgic characterization Vlithin 
kindreds of interest. Comprehensive identification and 
charactelization of mtilleIian anomalies "Within kin ships 
would allow genetic linkage analysis to help identify 
potentially important genes underlying these common 
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developmental anomalies. Also, a geographic localiza-
Lion of cases "With correlation to knm'vn toxic e.xposures 
during gestation may provide evidence of an environ-
mental contribution to the development of mtillerian 
anomalies. 
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